Mark H. Lawrence - 02 Mar 2023 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Mar 2023, 17:34:21 UTC
Prior SEC filing
23 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gregory Belliston as Attorney-in-Fact for Mark Lawrence

Key filing fact

Mark H. Lawrence filed Form 4 for NU SKIN ENTERPRISES, INC. (NUS) on 03 Mar 2023.

Key facts

  • This page summarizes Mark H. Lawrence's Form 4 filing for NU SKIN ENTERPRISES, INC. (NUS).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Mar 2023, 17:34.

Change

  • Previous filing in this sequence was filed on 23 Feb 2023.
  • Current net transaction value: -$517,327.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUS transaction

Class A Common Stock

Options Exercise

Transaction value
$549,348
Shares
+18,041
Change %
+28%
Price
$30.45
Shares after
83,290
Date
02 Mar 2023
Ownership
Direct
NUS transaction

Class A Common Stock

Sale

Transaction value
$1,066,675
Shares
-26,144
Change %
-31%
Price
$40.80
Shares after
57,146
Date
02 Mar 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUS transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-18,041
Change %
-15%
Price
$0.000000
Shares after
100,000
Date
02 Mar 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
18,041
Exercise price
$30.45
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.46 to $41.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Footnote F2

Currently exercisable in full.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .